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ABSTRACT
INTRODUCTION Observational studies indicate that cigarette package inserts with 
efficacy messages about the benefits of quitting (i.e. response efficacy) and 
recommendations for successful cessation increase smokers’ self-efficacy to 
quit and promote sustained cessation. However, the effects of inserts with such 
efficacy messages have not been studied using experimental designs. This study 
used ecological momentary assessment (EMA) to assess smokers’ responses to 
efficacy inserts. 
METHODS In a randomized case-crossover study among smokers from the United 
States (n=23), participants received a one-week supply of cigarettes with efficacy 
inserts and a one-week supply without any inserts, and were randomized to use 
the packs with inserts on either the first or second week of the study. For 14 
consecutive days, participants used a smartphone to answer brief surveys on 
cessation-related variables during smoking sessions and at the beginning of each 
day. Multilevel mixed-effects linear and logistic regression models compared 
responses during the insert period to those of the non-insert period. 
RESULTS The insert period was associated with greater desire to quit (b=0.21, 
p=0.012), motivation to quit (b=0.18, p=0.001), self-efficacy to cut down 
(b=0.26, p<0.001) and to quit (b=0.28, p<0.000), and response efficacy/
perceived benefits of quitting (b=0.13, p=0.012). Insert exposure was not 
significantly associated with forgoing cigarettes (OR=1.9, p=0.2). 
CONCLUSIONS Results from this EMA study suggest that inserts with efficacy 
messages may promote determinants of smoking cessation. This is consistent 
with observational research in Canada, which is the only country to use inserts 
with efficacy messages as well as pictorial warnings about smoking risks on 
the outside of packs. Future studies should assess the extent to which efficacy 
inserts can not only be used to communicate health information to smokers but 
also work in synergy with pictorial warnings.
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INTRODUCTION
While many countries and jurisdictions have 
implemented pictorial health warning labels 
(HWLs) on the outside of cigarette packs, Canada is 
the only country that also requires complementary 
messaging on inserts inside the packs. Canadian 
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inserts include supportive health messages on the 
benefits of quitting (i.e. response efficacy messages) 
and recommendations for successful smoking 
cessation (i.e. self-efficacy messages). Observational 
studies suggest that these inserts increase smokers’ 
self-efficacy to quit1 and promote quit attempts and 
sustained smoking cessation1,2. Further, experimental 
studies indicate that smokers perceive inserts with 
Canadian-style efficacy messages to be motivating 
and useful for quitting3,4. The current study assessed 
the real-world effects of inserts on cessation-related 
variables among a sample of smokers from the 
United States.
The cessation-related effects of pictorial HWLs 
that highlight smoking risks using graphic imagery 
appear to be partially due to increased negative 
affect, including fear5. As suggested by fear-appeal 
research and theories6,7, a combination of self-efficacy 
and response efficacy messages can enhance fear-
appeal messages and promote desirable attitudinal 
and behavioral change independent of fear arousal. 
However, the effects of inserts with efficacy messages 
have not been assessed in experiments outside brief, 
one-time exposures to messages online3,4.  Further 
research is needed to determine if these supportive 
messages are effective.
This study used ecological momentary assessment 
(EMA) methods to assess smokers’ real-time 
responses to inserts with efficacy messages in the US, 
where warning labels are small and do not include 
pictures. EMA has been used in observational studies 
to assess smokers’ responses to pictorial HWLs with 
fear-arousing content8-10, but not to assess responses 
to efficacy messages on inserts. While the primary 
purpose of this study was to test the feasibility of 
the study procedures, we expected that the period of 
exposure to efficacy inserts would be associated with 
greater self-efficacy to reduce and completely quit 
smoking, response efficacy, motivation and desire to 
quit, and forgoing cigarettes, when compared to the 
period without exposure to efficacy inserts. 
METHODS
Sample
Data collection occurred between 19 July 2017 
and 11 February 2018, in South Carolina and New 
York. Smokers in South Carolina were recruited 
through e-mail, Facebook, Craigslist, and Instagram 
advertisements. Smokers in New York were recruited 
through word-of-mouth and street intercepts outside 
tobacco shops. Potential participants completed an 
online survey to assess eligibility, which included: 
smoking at least 100 cigarettes in their lifetime; 
being a daily smoker; smoking 10 or more cigarettes 
per day; being 18–50 years of age; planning to quit 
sometime in the future; and no use of e-cigarettes or 
any other combustible/smokeless tobacco product in 
the prior month.  
Study protocol
EMA involves using mobile devices to query 
participants at critical moments, such as during 
smoking sessions when people are exposed to 
messages on and in cigarette packages, potentially 
mitigating recall bias11. For this study, EMA data 
were collected using smartphones programmed with 
a customized app installed and other device functions 
disabled (http://www.utas.edu.au/health/research/
groups/behavioural-and-situational-research-group-
bsrg/hbart). 
Participants attended a pre-study orientation that 
involved: confirmation of smoking status using a 
carbon monoxide breathalyzer (minimum 8 ppm CO 
required); a brief survey; and training in the study 
protocol. Participants were given a two-week supply 
of their preferred cigarette brand variety: one week’s 
supply with inserts and one week’s supply without 
inserts. Participants were randomized to use the 
supply with inserts on either the first or second week 
of the study. Packs with inserts contained one of four 
different insert messages, and participants received 
at least one of each of the four messages in their 
supply.  Of the four insert messages, two contained 
response efficacy information and two contained 
self-efficacy information, all of which included the 
phone number for a smoking cessation quit-line 
and website (smokefree.gov; see Supplementary 
Appendix). Each week’s supply was labeled as ‘Set 
1’ or ‘Set 2’ and placed in separate, zip-locked bags 
labeled with the days on which participants should 
use the packs. 
Participants used the smartphone provided to 
complete a survey each morning and to indicate 
each time they smoked a cigarette during the 14 
consecutive days of the study period. The morning 
survey queried how long ago the participant had 
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awaken and if they had stubbed out a cigarette early or 
not smoked when they intended to do so in the prior 
24 hours (i.e. forgoing). As a manipulation check 
of insert exposure, the morning log also prompted 
participants to take a photo of their cigarette pack.
Participants could log cigarettes at any time of 
day, and, when they logged a cigarette, the app 
queried whether they were smoking and if the 
current cigarette was from a new pack. Participants 
were prompted to complete a brief survey (i.e. 
event-related survey) every time they opened a new 
pack and, on average, at three additional, randomly 
selected smoking events each day (the algorithm 
considered the baseline quantity of cigarettes 
smoked per day in determining the frequency of 
surveys). Event-related surveys queried feelings 
about smoking, desire to quit smoking, motivation 
to quit smoking, self-efficacy to reduce smoking, 
self-efficacy to quit smoking, response efficacy 
(i.e. perceived benefits of quitting), and worry 
about the effects of smoking (see Table 1 for 
question wording). After the 14-day EMA period 
ended, participants attended a de-briefing session, 
during which they completed an online survey on 
perceptions of the insert messages, participated 
in a qualitative interview to discuss any issues 
completing the study protocol, and received US$150 
in remuneration, along with a pamphlet containing 
information on free smoking-cessation resources. 
Analyses
Multilevel mixed-effects linear and logistic models 
regressed outcomes from event-related surveys and 
morning reports on an indicator variable for the 
period when participants were exposed versus not 
exposed to inserts, controlling for week of insert 
exposure (i.e. 1st  vs  2nd week). For outcomes that 
were measured multiple times per day (i.e. event-
related surveys), three-level models were estimated, 
considering observations as nested within days 
Table 1. Results for key outcomes, comparing the period with exposure versus without exposure to inserts with 
efficacy messagesa
Variable Item
Response format and 
options (slider) Coef. (SE)
Feeling toward smoking Right now, you feel like smoking is…? 1 = very bad 
to
7 = very good
-0.10 0.06
Desire to quit How strong is your desire to quit at this time? 1= not at all strong 
to
7= extremely strong
0.21* 0.08
Motivation to quit How motivated are you to quit smoking? 1= not at all 
to
7= extremely
0.18*** 0.06
Self-efficacy to cut down How easy would it be to cut down on the number of 
cigarettes you smoke?
1 = not at all easy 
to
9 = extremely easy
0.26*** 0.08
Self-efficacy to quit How confident are you that you could quit smoking 
altogether right now?
1 = not at all confident
to
7 = extremely confident
0.28*** 0.06
Response efficacy How much would quitting smoking now reduce your 
chances of getting a serious disease?
1 = no chance 
to
7 = certain to happen
0.13* 0.05
 Worry about the risks of 
smoking
How worried are you about the possible effects of 
smoking?
1 = not at all worried
to
7 = extremely worried
-0.07 0.07
Forgoing cigarettes (odds 
ratio)b
In the last 24 hours, have you stubbed out a cigarette early 
or not had a cigarette when you would normally?
Yes/No 1.9 0.90
a Models were estimated separately for each outcome and adjusted for multiple responses by each individual as well as the week in which participants were exposed to inserts 
(i.e. 1st vs 2nd week of study). Models include data from 23 participants. b Forgoing was assessed once each day. All other outcomes in Table 1 were assessed multiple times each 
day, around smoking events.  *p<0.05,   **p<0.01,  ***p<0.001.
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and within participants. For the forgoing outcome, 
which was measured once daily, two-level models 
considered observations nested within participants 
only.  Stata 15 was used for all analyses (StataCorp. 
2017. Stata Statistical Software: Release 15. College 
Station, TX: StataCorp LLC). 
RESULTS
Compliance and descriptive findings
Participants reported no serious issues with 
completing the protocol.  Of the 28 participants who 
began the study, 27 completed it. Four of these 27 
participants were excluded from analysis because 
information acquired from the follow-up interview 
and the manipulation checks indicated they were 
not exposed to the inserts as assigned. Three 
participants did not use the insert and non-insert 
packs as assigned, and one participant indicated that 
he never saw the inserts, which was likely because 
they were hidden due to the type of pack for his 
preferred brand. 
For the analytic sample of 23 smokers, the mean 
age was 36.2 years, and about half (52%) was female, 
half intended to quit within the next 6 months 
(48%), and a third (35%) had attempted to quit in 
the prior 4 months. The mean Heaviness of Smoking 
Index12 was 3.41 (SE=0.22).  The total number of 
cigarettes logged was 2744 (with a mean, M=8.86 
per day during insert period, and M=9.08 per day 
during non-insert period). On average, participants 
completed 13.7 (of 14) days of the study protocol, 
40.6 event-related surveys, and 10.4 (of 14) morning 
reports throughout the study period. Compliance 
with the event-related surveys ranged from 88 to 
100%. The average number of days exposed to 
inserts was 6.8 (of 7).
Insert vs non-insert period
Table 1 shows the results from the mixed-effects 
regression models, comparing observations during 
the period when participants were exposed to 
inserts and when they were not. The insert period 
was associated with greater desire to quit (b=0.21, 
SE=0.08, p=0.01), stronger motivation to quit 
(b=0.18, SE=0.06, p=0.001), stronger self-efficacy 
to cut down (b=0.26, SE=0.08, p=0.001) and to quit 
(b=0.28, SE=0.06, p<0.000), and greater response 
efficacy (b=0.13, SE=0.05, p=0.01). Insert exposure 
was not significantly associated with feeling toward 
smoking (b=-0.10 SE=0.06, p=0.10), worry about 
the effects of smoking (b=-0.07, SE=0.07, p=0.33) 
or forgoing cigarettes (OR=1.9, SE=0.9, p=0.2). 
The order of insert exposure (i.e. 1st  vs 2nd week) 
was not significantly associated with any outcome 
(results not shown). 
DISCUSSION
The EMA protocol used in this study appears 
acceptable and feasible. While the findings should 
be confirmed in a larger study, five of the six study 
hypotheses regarding the positive effects of insert 
exposure on determinants of smoking cessation 
were supported. The findings that insert exposure 
was positively associated with self-efficacy to cut 
down and quit are particularly important since 
there is ample evidence that increasing self-efficacy 
promotes smoking cessation13-16. 
Contrary to our hypothesized expectation, we did 
not find a statistically significant association between 
insert exposure and forgoing cigarettes, although 
the coefficient suggested a tendency towards more 
forgoing when exposed to inserts. We had relatively 
low power to detect this effect because data on 
forgoing were only collected once a day compared 
to multiple times a day for the other study outcomes. 
Larger sample sizes and longer follow-up are likely 
necessary to better assess forgoing cigarettes, which 
consistently predicts quit attempts17-19.  Overall, 
our results suggest that inserts have medium-sized 
effects20 on determinants of cessation; however, 
these effects may partly reflect demand-effects from 
our case-crossover design, which did not blind 
participants to the experimental period.  Between-
subject study designs would better control for this 
potential bias but would likely require larger sample 
sizes. 
Our study had some additional limitations, 
including the inability to assess cessation behavior 
over a short period of time. Similarly, it is also 
unclear how long insert effects would be sustained 
given evidence21,22 of ‘wear out’ for HWLs; 
nevertheless, observational research in Canada 
found that attention to inserts increased over time, 
even while attention to HWLs dissipated1. More 
research is needed to confirm study findings and 
better inform cigarette labeling policy. Future 
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studies should assess potentially synergistic effects of 
inserts and HWLs, since theory suggests that efficacy 
messages can enhance the effects of fear-arousing 
messages7 and HWL research suggests that fear 
arousal might promote more deliberate processing 
of labeling messages23. Furthermore, although 
theory emphasizes the importance of both response 
efficacy and self-efficacy messages, future research 
could investigate this premise by assessing their 
independent effects on cessation-related outcomes.
CONCLUSIONS 
The preliminary findings from this pilot study suggest 
that efficacy messages promote determinants of 
cessation. These findings warrant further assessment 
in larger trials that randomize participants to 
different labeling conditions, including assessment 
of potential synergies between efficacy messages and 
fear-arousing messages.
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